Sleep apnea affects over 29 million Americans, with Obstructive Sleep Apnea (characterized by pauses in breathing during ...

It can also contribute to the risk of high blood pressure, heart disease, stroke, and other serious conditions. One way to treat sleep apnea is with a CPAP machine—a mask and hose that is worn over ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

Q2 2025 Management View CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, ...

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

Auto-titrating continuous positive airway pressure, or AutoCPAP therapy, is useful for the treatment of obstructive sleep apnea. It is delivered via a face mask and tubing that attaches to a device ...

While Continuous Positive Airway Pressure (CPAP) machines have long been the standard treatment, many patients find them uncomfortable or difficult to use. Fortunately, Sleep Solution Centers, a ...

UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...

January is almost over. For most of us, that means the making and breaking of New Year’s resolutions will (thankfully) be done with for another year.